Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors

被引:112
作者
Kazmierski, W
Bifulco, N
Yang, HB
Boone, L
DeAnda, F
Watson, C
Kenakin, T
机构
[1] GlaxoSmithKline Res & Dev Ltd, Dept Med Chem, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline Res & Dev Ltd, Dept Virol, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline Res & Dev Ltd, Computat Analyt & Struct Sci, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline Res & Dev Ltd, Syst Res, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1016/S0968-0896(03)00161-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review addresses key pharmacology and virology issues relevant in discovery and development of CCR5 antagonists as anti-HIV drugs, such as target validation, receptor internalization, allosterism, viral resistance and tropism. Recent progress in the discovery and development of CCR5 antagonists, SAR and clinical status are reviewed. Finally, modeling-based structure of CCR5 is discussed in the context of a small-molecule antagonism of the CCR5 receptor. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2663 / 2676
页数:14
相关论文
共 157 条
[41]   HIV-1 entry and macrophage inflammatory protein-1 beta-mediated signaling are independent functions of the chemokine receptor CCR5 [J].
Farzan, M ;
Choe, H ;
Martin, KA ;
Sun, Y ;
Sidelko, M ;
Mackay, CR ;
Gerard, NP ;
Sodroski, J ;
Gerard, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :6854-6857
[42]   Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection [J].
Farzan, M ;
Choe, H ;
Martin, K ;
Marcon, L ;
Hofmann, W ;
Karlsson, G ;
Sun, Y ;
Barrett, P ;
Marchand, N ;
Sullivan, N ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (03) :405-411
[43]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 3:: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)4-[4-(substituted)piperidin-1yl]butanes [J].
Finke, PE ;
Meurer, LC ;
Oates, B ;
Shah, SK ;
Loebach, JL ;
Mills, SG ;
MacCoss, M ;
Castonguay, L ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) :2469-2473
[44]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes [J].
Finke, PE ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA ;
Carella, A ;
Carver, G ;
Holmes, K ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Schleif, WA ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) :2475-2479
[45]   Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 2:: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes [J].
Finke, PE ;
Meurer, LC ;
Oates, B ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Daugherty, BL ;
Gould, SL ;
DeMartino, JA ;
Siciliano, SJ ;
Carella, A ;
Carver, G ;
Holmes, K ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Schleif, WA ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) :265-270
[46]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517
[47]   THE ENERGY LANDSCAPES AND MOTIONS OF PROTEINS [J].
FRAUENFELDER, H ;
SLIGAR, SG ;
WOLYNES, PG .
SCIENCE, 1991, 254 (5038) :1598-1603
[48]   PROTEINS - PARADIGMS OF COMPLEX-SYSTEMS [J].
FRAUENFELDER, H .
EXPERIENTIA, 1995, 51 (03) :200-203
[49]  
FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451
[50]   β-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK [J].
Ganju, RK ;
Dutt, P ;
Wu, LJ ;
Newman, W ;
Avraham, H ;
Avraham, S ;
Groopman, JE .
BLOOD, 1998, 91 (03) :791-797